Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
MEISYS is a Spanish medical science consulting and outsourcing service provider, legally operating as MEDIACIÓN CIENTÍFICA, S.L. It provides services related to medical affairs, regulatory affairs, pharmacovigilance, quality, and training for pharmaceutical companies and the biohealth industry. Based on the collected content, it is not a typical SaaS product, but rather a provider centered on professional knowledge services and functional outsourcing.
Its services cover Medical Information / PSP, Medical Affairs, Pharmacovigilance, scientific documentation, Medical Governance, Regulatory Affairs, Quality Assurance, and training. The website emphasizes that its team is made up 100% of healthcare professionals, has more than 15 years of industry experience, has served over 200 laboratories, covers all therapeutic areas, and can support product types including human medicines, veterinary medicines, medical devices, food supplements, and cosmetics. For pharmaceutical companies, its main value lies in outsourcing medical and regulatory functions, accessing local regulatory and health administration expertise, and obtaining specialized or end-to-end support as needed.
The main content does not disclose standard packages, subscription pricing, free trials, or payment methods, so pricing is likely customized. Although the website has login/register entry points, it does not state whether it provides a customer portal, workflow system, access control, APIs, third-party integrations, or self-hosted deployment. Therefore, it should not be regarded as a mature enterprise software platform. In terms of data compliance, the privacy policy states that it follows the EU GDPR, does not transfer data to third parties except where legally required, does not conduct international data transfers, and does not make automated commercial profiling decisions. Website analytics use Google Analytics.
Its strengths are its strong industry focus, comprehensive service modules, customer base, and evidence of repeat business, making it suitable for life sciences companies that need support in medical affairs, pharmacovigilance, or regulatory affairs. Its limitations are relatively low information transparency, with a lack of pricing, delivery SLAs, detailed case studies, and explanations of digital platform capabilities. For teams procuring enterprise software, there is insufficient information on integrations, permissions, APIs, and deployment.
It is better suited for pharmaceutical companies, biotech firms, and healthcare startups operating in the Spanish or EU markets that need medical science consulting, regulatory compliance, and functional outsourcing. The main content does not specify access from China, so its availability is unknown.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on meisys.es official site.
meisys.es is an Spain SaaS provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach meisys.es directly.